Company description:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

Job description:

Join Us in Changing Lives

At OXB, our people are at the heart of everything we do. Were on a mission to enable life-changingtherapies to reach patients around the worldand were looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.

Were currently recruiting for a Finance Manager to join our UK Finance Control Team. In this role, you willbe managing the team whose goal it is to maintain the financial integrity of the general ledger to allow for the efficient closure of the management accounts and year-end Financial Statements.

Your responsibilities in this role would be:

• Managing a team of two, providing leadership, support, and development.
• Preparing and analysing financial data to understand key performance drivers, ensuring accurate financial statement treatment.
• Calculating key assumptions within your area of responsibility for both annual and interim reporting.
• Producing clear and insightful reporting and commentary to support understanding of financial results.
• Preparing departmental deliverables, such as management accounts packs, for review prior to external distribution.
• Operating key financial controls within the Financial Control team, and maintaining accurate records for your assigned controls.
• Ensuring accounting systems and processes are effectively managed and documented, including leading system upgrades and proposed changes.

We are looking for:

• Educated to degree level in Finance, Accounting, or a related discipline, or possess equivalent professional experience
• Fully qualified accountant (CA, ACCA, ACA or equivalent)
• Proven experience as a qualified accountant in a corporate finance environment, including journal preparation and account reconciliations
• Strong understanding of financial reporting, controls, and business processes
• Proficient in ERP systems and financial transactions
• Competent Excel skills, with the ability to work confidently with spreadsheets and data in a finance environment
• Demonstrated ability to work collaboratively across functions and influence stakeholders effectively
• Experienced people manager with a track record of leading and developing finance teams

About Us:

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

Why Join Us?

• ??Competitive total reward packages
• ??Wellbeing programmesthat support your mental and physical health
• ??Career development opportunitiesto help you grow and thrive
• ??Supportive, inclusive, and collaborative culture
• ??State-of-the-art labs and manufacturing facilities
• ?? A company that lives its values:Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, were future-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

Profile description:

About Us:

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

Why Join Us?

• ??Competitive total reward packages
• ??Wellbeing programmesthat support your mental and physical health
• ??Career development opportunitiesto help you grow and thrive
• ??Supportive, inclusive, and collaborative culture
• ??State-of-the-art labs and manufacturing facilities
• ?? A company that lives its values:Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, were future-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

JBRP1_UKTJ